Pharmaceutical SEO in Montréal,
built for the Canadian framework.

If you are looking for a "PAAB agency", what you actually need is PAAB expertise — not a generalist agency that treats pharma like any other account. Canadian pharmaceutical SEO stands or falls on PAAB and Health Canada compliance, so the work is led directly by a specialist who has worked inside the industry, rather than delegated to a junior. You get agency-grade SEO with regulatory judgement a generalist shop cannot offer.

A generalist agency knows SEO but not the Canadian pharmaceutical regulatory framework. It risks optimizing Rx product pages (a PAAB violation) or applying US rules (HIPAA, FDA) that do not apply in Canada. A specialized consultant masters PAAB, Health Canada, the ban on direct-to-consumer (DTC) advertising, and the E-E-A-T requirements of YMYL content.

In Canada, direct-to-consumer advertising of prescription drugs is banned and advertising to healthcare professionals is pre-approved by PAAB. In the US, DTC is legal and the FDA acts post-market. An SEO strategy designed for the US market (HIPAA, FDA) creates regulatory violations if applied as-is in Canada.

The SEO + GEO compliance audit starts at CA$997: technical audit, content audit, PAAB regulatory audit and AI visibility audit, with a score out of 100 and a prioritized action plan, delivered within 10 business days.

Yes. All reports, strategies and content are produced in both French and English, with an understanding of the regulatory nuances in each language — essential for the bilingual Canadian pharmaceutical market.

Yes. GEO (Generative Engine Optimization) is built into every engagement: question/answer content structure, FAQ JSON-LD schemas, structured data and extractable passages to be cited in the generative AI answers used by healthcare professionals.

No. Direct-to-consumer advertising of prescription drugs is prohibited in Canada under the Food and Drugs Act. A manufacturer cannot both name a prescription drug and describe its use in a consumer-facing ad. Only Health Canada–authorized products may be advertised at all.

Technically voluntary, but mandatory in practice: Health Canada recognizes PAAB to preclear prescription-drug advertising, and medical publications require a PAAB approval number before they will run an ad. Skipping it exposes you to complaints and content removal.

A standard first submission is reviewed in about 10 business days, followed by shorter follow-up rounds until the material is accepted. Because most submissions need at least one revision, plan for several weeks rather than days.

Advertising promotes the sale of a product and is regulated. Non-promotional information — factual disease education that does not push a specific branded product — falls outside advertising rules. Health Canada 2023 guidance clarifies that line and shapes how you write web content.